NCT00671931View on ClinicalTrials.gov

Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Scoliosis
Interventions
DRUG

low dexmedetomidine, low propofol

Dexmedetomidine loading dose 0.6 MCG/KG,Propofol infusion 100 MCG/KG/M

DRUG

high dexmedetomidine, low propofol

Dexmedetomidine loading dose 1.1 MCG/KG ,Propofol infusion 100 MCG/KG/M

DRUG

Dexmedetomidine

Dexmedetomidine loading dose 0.6 MCG/KG,Propofol infusion 200 MCG/KG/M

DRUG

Dexmedetomidin

Dexmedetomidine loading dose 1.1 MCG/KG.Propofol infusion 200 MCG/KG/M

DRUG

Dexmedetomidine

Dexmedetomidine loading dose 0.9 mcg/kg,Propofol infusion 140 mcg/kg/min

Trial Locations (1)

45229

Cincinati Children Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT00671931 - Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine | Biotech Hunter | Biotech Hunter